Scott A. Small
No shipping costs from €15
Gifts wrapped for free
Ordering without an account possible
30 days exchange period for physical products
Scott A. Small MD is the Director of the Alzheimer's Disease Research Center at Columbia University. Dr. Small's lab focuses on disorders that effect the hippocampus, a brain circuit targeted by Alzheimer's disease, the normal wear & tear of the aging process ('cognitive aging'), and schizophrenia. The lab first optimized MRI tools applicable to patients and animal models that were then used to pinpoint the parts of the hippocampal circuit differentially vulnerable and resistant to each disorder (Nature Reviews Neuroscience, 2011). This anatomical information was then used as a guide to uncover pathogenic drivers (Neuron, 2014): Retromer-dependent endosomal recycling in Alzheimer's disease, dietary flavanols in cognitive aging, and the glutamate metabolic cycle in schizophrenia. Most recently, his lab has been developing interventions and biomarkers for each disorder, and the lab's discoveries were the cornerstone for the formation of a new biotechnology company, Retromer Therapeutics
Forgetting
The New Science of Memory
Second hand products
-
Looking for second hand products...
Description
An exploration into why not remembering is good for your brain, by a leading memory expert
Scott A. Small MD is the Director of the Alzheimer's Disease Research Center at Columbia University. Dr. Small's lab focuses on disorders that effect the hippocampus, a brain circuit targeted by Alzheimer's disease, the normal wear & tear of the aging process ('cognitive aging'), and schizophrenia. The lab first optimized MRI tools applicable to patients and animal models that were then used to pinpoint the parts of the hippocampal circuit differentially vulnerable and resistant to each disorder (Nature Reviews Neuroscience, 2011). This anatomical information was then used as a guide to uncover pathogenic drivers (Neuron, 2014): Retromer-dependent endosomal recycling in Alzheimer's disease, dietary flavanols in cognitive aging, and the glutamate metabolic cycle in schizophrenia. Most recently, his lab has been developing interventions and biomarkers for each disorder, and the lab's discoveries were the cornerstone for the formation of a new biotechnology company, Retromer Therapeutics
Specifications
Publisher
Canelo
Pub date
May 22, 2025
Pages
224
Theme
Alzheimer’s and dementia
Measurements
198 x 129 x 10 mm
EAN
9781804369661
Binding
Paperback
Language
English